Cancer Communications (Nov 2019)
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Abstract
No abstracts available.
Cancer Communications (Nov 2019)